Skip to content
value.today

Ergomed

ERGO.L
$711 Mlast known market cap, Jul 2023 — no current value
Compare
World rank
—
no current market cap
Revenue
$186 M
Dec-2022 ending year
value.today research
Net income
$19 M
10.2% margin
value.today research
Employees
—

Ergomed in brief

Ergomed is a listed company in the Biotechnology industry, based in the UK. It was founded in 1997. Its last known market value was $711 M (July 2023); there is no current figure. In the year to Dec 2022 it had sales of $186 M and a net profit of $19 M, about 10 cents of profit for every dollar of sales. Its shares trade under the symbol ERGO.L (LSE).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

Ergomed timeline

1 events, 1997
  1. 1997
  2. 🏁
    · approximate
    Founded

Events of Ergomed from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$239 M$479 M$718 M$958 M2020202120222023

World rank over time

▲ up 4,008 places since 2020
2020-01-01: #14598#14,59820202021-01-01: #9683#9,68320212022-01-07: #10055#10,05520222022-12-25: #9546#9,54620222023-07-30: #10590#10,5902023

Rank in UK: #404 (Jan 2020) · #461 (Jan 2021) · #472 (Jan 2022) · #349 (Dec 2022) · #386 (Jul 2023)

Key ratios

market cap and latest results
P/E ratio
—
Price / sales
—
Price / book
—
Free cash flow yield
—
Net margin
10.2%
Operating margin
14.0%
Return on equity
17.4%
Liabilities / assets
34.3%

Annual results

Revenue
$186 M
Operating income
$26 M
Net income
$19 M

Dec-2022 ending year

Balance sheet

Total assets
$166 M
Total liabilities
$57 M
Total equity
$109 M

Dec-2022 ending year

How Ergomed compares in Biotechnology

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Ergomed🇬🇧$711 M—10.2%—
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jul 30, 2023 (last known)
Annual results:
Dec-2022 ending year
Balance sheet:
Dec-2022 ending year
Profile updated:
Nov 4, 2026

Figures from value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Ergomed? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Ergomed's ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Ergomed? Suggest a correction